Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0116900004
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 00886971 | FRESENIUS KABI CANADA LTD | CEFTAZIDIME FOR INJECTION, USP | Human | Yes | Prescription | 1 | CEFTAZIDIME | 1 G / VIAL |
Cancelled Post Market | 01974408 | GLAXO CANADA INC | CEPTAZ INJ 1GM/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 1 G / VIAL |
Cancelled Post Market | 02215012 | GLAXOSMITHKLINE INC | CEPTAZ INJECTION - PWS IM IV 1G/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 1 G / VIAL |
Cancelled Post Market | 00887129 | ELI LILLY CANADA INC | TAZIDIME ADD-VANTAGE INJ 1.0GM/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 1 G / VIAL |
Application information
Related information
Contact us
Version 4.0.3